Clinical trial Recruiting at 3 sites Interventional Ages 18 Months to 80

Electrical stimulation for chronic upper limb pain relief

Official title: Treatment of Upper Limb Chronic Neuropathic Pain by Electrical Stimulation of the Brachial Plexus Nerve Roots

Run by Centre Hospitalier Universitaire de Nice · NCT05817786 · Data updated 2026-11-12

This study is testing if electrical stimulation of certain nerves can help people with chronic pain in their arms feel better when other treatments haven’t worked.

Quick facts

Study typeInterventional
Ages18 Months to 80 Years
SexAll
Enrollment48 (estimated)
SponsorCentre Hospitalier Universitaire de Nice
Academic / other
Locations3 sites (Lyon, France and 2 other locations)
StatusRecruiting
StartedFebruary 9, 2024
Main results expectedJuly 9, 2026
Study endsJuly 1, 2027
Registry record updatedMarch 19, 2025
Trial IDNCT05817786 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 80 with moderate to severe unilateral chronic neuropathic pain in the upper limb that has persisted for over 12 months and is refractory to first and second line treatments.

Probably not a fit

Patients with brachial plexus avulsion or post-zoster neuropathy may not benefit from this treatment.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of electrical stimulation of the brachial plexus nerve roots in alleviating moderate to severe chronic neuropathic pain in the upper limb. The study employs a controlled approach to assess pain relief, quality of life improvements, and safety outcomes in patients who have not responded to conventional treatments. Participants will receive either active stimulation or sham stimulation, with the implantation technique guided by ultrasound for precision. The trial aims to provide robust evidence on the efficacy of this novel neuromodulation technique.

Why it matters

Potential benefit: If successful, this treatment could significantly reduce chronic pain and improve the quality of life for patients suffering from neuropathic pain in the upper limb.

How similar studies have gone: While peripheral nerve stimulation has shown promising results in small series, this specific approach for brachial plexus stimulation has not been extensively evaluated in controlled conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Eligibility will be determined by trained clinicians with expertise in chronic pain and neuropathic pain.
* Patients between 18 and 80 years old
* suffering from moderate to severe (VAS score \>5/10) chronic (duration\> 12 months) neuropathic (DN4 score ≥ 4/10) unilateral pain - located in the upper limb.
* from peripheral origin, including complex regional pain syndrome type I and II, post-traumatic or post surgical pain.
* refractory to first and second line treatments for neuropathic pain according recent French recommendations and guidelines\[6\], including serotonin- noradrenaline reuptake inhibitor (SNRI) antidepressants (duloxetine and venlafaxine), gabapentin, pregabalin, tricyclic antidepressants, topical lidocaine, high-concentration capsaicin patches, psychotherapy and combinations of them.

Patient have signed informed consent

\- Patient benefiting from French social insurance system

Exclusion Criteria:

* Brachial plexus avulsion
* Post-zoster neuropathic pain
* Phantom limb pain
* Patient unable to fill a self-administered questionnaire
* Patients with a chronic disease requiring repeated MRI monitoring
* Patients with contra-indication to general anesthesia, surgery or percutaneous BP approach.
* Patients with other pacemakers (cardiac pacemaker or defibrillator) or patients with a high risk to use a defibrillator due to a known cardiac disorder.
* Patients with instable neuropsychological or psychiatric disorders
* Vulnerable patients: pregnant or breast feeding, minor, adult under guardianship or deprived freedom

Where it's running

  • CHU de Lyon
    Lyon, France, France
    Recruiting
  • CHU de Nice
    Nice, France, France
    Recruiting
  • CHU de Poitiers
    Poitiers, France, France
    Recruiting

Study contacts

  • Principal investigator: Denys FONTAINE — Centre Hospitalier Universitaire de Nice
  • Study coordinator: Denys Fontaine
  • Email: fontaine.D@chu-nice.fr
  • Phone: 0492034702

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.